PrednisoneGlucocorticoidsDexamethasoneReceptors, GlucocorticoidVincristinePrednisoloneMifepristoneHydrocortisoneCyclophosphamideAnti-Inflammatory AgentsCorticosteroneAdrenalectomyDoxorubicinImmunosuppressive AgentsProcarbazineAntineoplastic Combined Chemotherapy ProtocolsAzathioprineMechlorethamineCortisoneMethylprednisolone11-beta-Hydroxysteroid Dehydrogenase Type 1Drug Therapy, Combination11-beta-Hydroxysteroid DehydrogenasesTreatment OutcomeHormone Antagonists11-beta-Hydroxysteroid Dehydrogenase Type 2TriamcinoloneMelphalanDrug Administration ScheduleAntibodies, Monoclonal, Murine-DerivedMitoxantroneBetamethasoneMethotrexateAdrenal Cortex HormonesRNA, MessengerRemission InductionBleomycinPituitary-Adrenal SystemTime FactorsHypothalamo-Hypophyseal SystemDose-Response Relationship, DrugColor TherapyLymphoma, Non-HodgkinCyclosporineHydroxysteroid DehydrogenasesAdministration, OralChlorambucilMineralocorticoidsMethylprednisolone HemisuccinateMycophenolic AcidHodgkin DiseaseLymphoma, Large B-Cell, DiffuseGene Expression RegulationMetyraponeMultiple MyelomaCells, CulturedAdrenocorticotropic HormoneTriamcinolone AcetonideFollow-Up StudiesReceptors, MineralocorticoidArthritis, RheumatoidVinblastineKidney TransplantationAsparaginaseAnnexin A1ThalidomideTacrolimusRecurrenceAntirheumatic AgentsEtoposideSurvival AnalysisTyrosine TransaminaseNephrotic SyndromeBeclomethasoneTranscription, GeneticGraft RejectionSteroidsDisease-Free SurvivalSurvival RateBudesonideLiverCortodoxoneFluoxymesteroneCombined Modality TherapyAdrenocortical HyperfunctionDouble-Blind MethodCorticotropin-Releasing HormoneCycloheximidePrecursor Cell Lymphoblastic Leukemia-LymphomaPulse Therapy, DrugCell LineImmunosuppressionStress, PhysiologicalAdrenal GlandsClinical Trials as TopicRetrospective StudiesRats, Sprague-DawleyProspective StudiesPolymyalgia Rheumatica6-Mercaptopurine